[go: up one dir, main page]

ATE460945T1 - Genetische adjuvanz-impfstoffe - Google Patents

Genetische adjuvanz-impfstoffe

Info

Publication number
ATE460945T1
ATE460945T1 AT07015414T AT07015414T ATE460945T1 AT E460945 T1 ATE460945 T1 AT E460945T1 AT 07015414 T AT07015414 T AT 07015414T AT 07015414 T AT07015414 T AT 07015414T AT E460945 T1 ATE460945 T1 AT E460945T1
Authority
AT
Austria
Prior art keywords
adjuvance
vaccines
genetic
inducing
nucleic acid
Prior art date
Application number
AT07015414T
Other languages
English (en)
Inventor
Joel R Haynes
Georg Widera
James T Fuller
Timothy Shipley
Deborah Fuller
Mary Wu
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Priority claimed from EP99956885A external-priority patent/EP1227840B1/de
Application granted granted Critical
Publication of ATE460945T1 publication Critical patent/ATE460945T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT07015414T 1999-11-03 1999-11-03 Genetische adjuvanz-impfstoffe ATE460945T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99956885A EP1227840B1 (de) 1999-11-03 1999-11-03 Genetische impstoffe mit adjuvans

Publications (1)

Publication Number Publication Date
ATE460945T1 true ATE460945T1 (de) 2010-04-15

Family

ID=38763704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07015414T ATE460945T1 (de) 1999-11-03 1999-11-03 Genetische adjuvanz-impfstoffe

Country Status (5)

Country Link
EP (1) EP1913957B1 (de)
AT (1) ATE460945T1 (de)
DE (1) DE69942161D1 (de)
DK (1) DK1913957T3 (de)
SI (1) SI1227840T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112569348B (zh) * 2019-09-29 2023-02-28 中国食品药品检定研究院 一种带状疱疹疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69529495T2 (de) * 1994-01-21 2003-06-12 Powderject Vaccines, Inc. Gasbetätigtes element zum austragen von genmaterial
AU6897098A (en) * 1997-04-14 1998-11-11 University Of Massachusetts Medical Center Saponin adjuvants in combination with dna vaccination
CA2312900A1 (en) * 1997-12-02 1999-06-10 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
GB9818627D0 (en) * 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
EP1227840B1 (de) * 1999-11-03 2007-10-03 Powderject Vaccines, Inc. Genetische impstoffe mit adjuvans

Also Published As

Publication number Publication date
EP1913957B1 (de) 2010-03-17
DK1913957T3 (da) 2010-05-10
SI1227840T1 (sl) 2008-02-29
EP1913957A1 (de) 2008-04-23
DE69942161D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
DK1487485T3 (da) Imidazoquinolinadjuvanser til DNA-vacciner
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE69929444D1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
CY1119650T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE60217320D1 (de) Gonokokkenproteine und nukleinsäuren
DK1047784T3 (da) Neissera meningitidis-antigener
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
CY1110585T1 (el) ΣΥΣΚΕΥΑΣΙΑ (ΠΑΚΕΤΑΡΙΣΜΑ) ΑΝΟΣΟΔΙΕΓΕΡΤIΚΩΝ CpG ΕΝΤΟΣ ΟΜΟΙΑΖΟΝΤΩΝ ΜΕ ΙΟ ΣΩΜΑΤΙΩΝ: ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΚΑΙ ΧΡΗΣΗ
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
DE60144201D1 (de) Lawsonia intracellularis Impfstoff
EP1315816A4 (de) Genmanipulierte dna-vakzine zur co-expression, methoden zu deren herstellung und deren verwendungen(18.03.02)
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
ATE284613T1 (de) Polynukleotid-impfstoff-formulierungen
ATE460945T1 (de) Genetische adjuvanz-impfstoffe
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
SE9903534D0 (sv) Vaccin
NO20041564L (no) Infeksios lakse anemi-virus vaksine
CY1105176T1 (el) Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας
DK1490100T3 (da) Kombinerede DNA/proteinvaccinepræparater
PT1176192E (pt) Vacina de helicobacter felis
Paoletti Recombinant avipox virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1913957

Country of ref document: EP

REN Ceased due to non-payment of the annual fee